Pending effectiveness of a regulatory filing, NYSE Arca proposes revisions to the NYSE Arca Equities Fee Schedule for shares with a price of $1.00 or above.
More
Pending effectiveness of a regulatory filing, NYSE Arca proposes revisions to the NYSE Arca Equities Fee Schedule for shares with a price of $1.00 or above.
More